Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025)

Benitec Biopharma has reported Other Non Operating Income for 7 years, with the latest figure at -$89000.0 in Q3 2025.

• Quarterly Other Non Operating Income fell 195.7% year-over-year to -$89000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$215000.0 (up 12.96% YoY) and the FY2025 annual result came in at -$131000.0, up 35.78% from the prior year.
• Other Non Operating Income improved to -$89000.0 in Q3 2025 per BNTC's latest filing, from -$126000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $152000.0 in Q4 2023 and troughed at -$507000.0 in Q3 2022.
• A 5-year average of -$85411.8 and a median of -$80000.0 in 2023 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 380.0% in 2021, down 1500.0% in 2021.
• Over 5 years, Other Non Operating Income stood at $48000.0 in 2021, then climbed by 4.17% to $50000.0 in 2022, then jumped by 204.0% to $152000.0 in 2023, then tumbled by 126.32% to -$40000.0 in 2024, then slumped by 122.5% to -$89000.0 in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$89000.0, -$126000.0, and -$40000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.